Dr. Debashish Chowdhury chairs this clinically focused case presentation. The session addresses the challenges of managing status migrainosus and reviews evolving emergency care protocols, emphasizing timely, evidence-based interventions in acute settings.

Special case: Status migrainosus and evolving ER protocols

Dr. Debashish Chowdhurychairs this case-based discussion Dr. Vikram Sharma with real-world insights. The session explores the evolving role of gepants in prophylaxis and their application in managing breakthrough migraine attacks, offering practical strategies for real-world clinical scenarios.

Special case: CGRP antagonists in Prophylaxis: Managing Breakthrough Attacks

Dr. Ashish Duggal chairs this evidence-driven keynote delivered by Dr. Debashish Chowdhury. The session delves into the significant personal and societal burden of migraine while evaluating the growing body of evidence supporting next-generation acute therapies, with a focus on improving patient outcomes.

Migraine Burden and the Evidence for Next-Generation Acute Therapies

RCP Migraine 2.0: Review of Current Practice in Migraine is a focused one-day virtual academic initiative dedicated to advancing contemporary migraine care through evidence-based discussions and real-world clinical insights. Scheduled for September 11th, 2026, this high-impact program brings together leading experts to address critical gaps in acute migraine management and explore emerging therapeutic paradigms.

Under the scientific leadership of Dr. Debashish Chowdhury, the conference will center on the evolving role of novel therapies, with a special focus on CGRP antagonists such as rimegepant, and their application in routine clinical practice.

The agenda is designed to deliver clinically relevant, practice-oriented insights, covering:
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs
- Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs - Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Burden of Migraine & Emerging Evidence – Clinical and patient-centric rationale for next-generation therapies - CGRP antagonists in Prophylaxis – Addressing breakthrough attacks and redefining preventive strategies
- Complex Case Discussions – Real-world approaches in migraine prophylaxis with newer agents and status migrainosus with evolving emergency care protocols

Through expert-led keynotes and case-based discussions, RCP Migraine 2.0 aims to bridge the gap between clinical evidence and real-world practice, enabling clinicians to make informed, patient-centric treatment decisions.

Join us for an engaging academic experience and stay at the forefront of innovation in migraine management.

RCP Migraine 2026

Dr. Debashish Chowdhury chairs this insightful keynote session featuring Dr. Subhash Kaul. The discussion critically examines the limitations of traditional acute therapies, including medication overuse, triptan resistance, and persistent unmet clinical needs, setting the stage for a paradigm shift in migraine management.

Why Conventional Acute Migraine Therapies Fall Short: Medication Overuse, Triptan Resistance, and Unmet Clinical Needs

After two highly engaging episodes, Meet the Expert returns on January 22 with its third edition—an in-depth exploration of acute migraine management, the CGRP pathway, and medication overuse headache, viewed through the prism of real-world clinical practice.

This distinctive, case-based format brings together neurologists from across the country who will present complex and thought-provoking migraine cases, each critically analysed by Dr. Debashish Chowdhury, one of India’s—and the world’s—leading authorities in Headache Medicine.

Navigating key diagnostic dilemmas and therapeutic decision-making, the discussion will highlight practical treatment strategies, emerging evidence, and the subtle clinical nuances that distinguish expert migraine care. Designed to encourage interactive dialogue and demystify challenging scenarios, this episode continues the Meet the Expert legacy of transforming routine clinical encounters into impactful learning experiences.

Meet The Expert: Episode 3

Chaired by Dr. Debashish Chowdhury and presented by Dr. Andrew Charles, this case-based session brings practice to the podium. Through two real-world cases, the session highlights how Rimegepant is being used in complex clinical scenarios - bridging evidence with experience and offering pearls for effective patient-centered care.

Experience Sharing: Rimegepant in Practice - 2 Clinicians, 2 Complex Cases

RCP Migraine: Review in Current Practice in Migraine is a two-day live virtual conference dedicated to advancing migraine care. Join leading experts as they explore the latest scientific advancements, clinical data, and real-world applications in migraine management. Stay at the forefront of migraine treatment with cutting-edge insights and evidence-based strategies.

Key Topics

🔷 Migraine Subtypes & Prevalence – Global and regional insights shaping clinical decisions

🔷 Current Treatment Paradigms – Addressing gaps in therapy for better patient outcomes

🔷 CGRP Antagonists & Beyond – The paradigm shift in acute and preventive strategies

🔷 Cutting-Edge Therapies – From Gepants to neuromodulation—what’s next?

🔷 Preventive Migraine Management – Evidence-based updates and guideline-driven approaches

🔷 Real-World Case Insights – Experience sharing on Rimegepant and its clinical implementation

This conference will provide practical takeaways to refine your approach to migraine care. Stay ahead and transform your migraine practice. Register now!

RCP Migraine Day 2

This session, chaired by Dr. Debashish Chowdhury and delivered by Dr. Andrew Charles, navigates the CGRP pathway’s therapeutic evolution - from injectable monoclonal antibodies to the newer class of oral CGRP receptor antagonists, Gepants. Attendees will gain clarity on their mechanisms, comparative benefits, and clinical applications in migraine prevention and acute management.

CGRP pathway: From MAb to Gepants

Dr. Debashish Chowdhury chairs this high-impact session with internationally acclaimed expert Dr. Peter Goadsby as keynote speaker. The session unpacks the complex neurobiology of migraine and focuses on the central role of CGRP, offering a mechanistic foundation for targeted therapies in practice today.

Pathophysiology of Migraine and role of CGRP

Chaired by Dr. Ashish Duggal, this session features Dr. Debashish Chowdhury exploring the current therapeutic landscape in migraine care. From conventional approaches to emerging treatments, the discussion dives deep into real-world usage patterns, unmet patient needs, and where the gaps in migraine therapy still lie - setting the tone for innovation and change.

Current Treatment Paradigms and Gaps in Therapy: What’s being used vs. what’s missing?

In this opening session, Dr. Debashish Chowdhury sets the stage by chairing a critical conversation on the evolving global burden of migraine, its shifting regional patterns, and persistent diagnostic gaps. Dr. Girish Kulkarni delivers the keynote, offering insights into current epidemiological trends, highlighting disparities in diagnosis, and emphasizing the urgent need for region-specific strategies as we move towards 2025.

Migraine in 2025: Global Burden, Regional Patterns & Diagnostic Challenges

RCP Migraine Day 1

Vice Chairman & Academic Head, BLK Max Super Speciality Hospital, New Delhi; Former Director-Professor of Neurology at the GB Pant Institute of Post Graduate Medical Education and Research, New Delhi

Dr. Debashish Chowdhury

13

6.9k

230.7k

4.8

Sessions Taken

610

4.9

598

4.8

636

4.8

552

4.8

589

4.8

723

4.8

1.6k

4.8

1.3k

4.8

1.5k

4.8

2k

4.7

2.2k

4.7

2.4k

4.7

1.6k

4.7